Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre hospitalier de l'Université de Montréal (CHUM)
Centre Oscar Lambret
Psyence Australia Pty Ltd
Daiichi Sankyo
HealthPartners Institute
OHSU Knight Cancer Institute
Mayo Clinic
Pfizer
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Elevation Oncology
Seagen Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
Exelixis
Universitair Ziekenhuis Brussel
Convalife (Shanghai) Co., Ltd.
Charite University, Berlin, Germany
pharmaand GmbH
M.D. Anderson Cancer Center
OncoNano Medicine, Inc.
Dana-Farber Cancer Institute
Seagen Inc.
Wake Forest University Health Sciences
Advanced Accelerator Applications
Eli Lilly and Company
University of Iowa
Maastricht Radiation Oncology
Duke University
National University Hospital, Singapore
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Stanford University
M.D. Anderson Cancer Center
Amgen
National Center for Complementary and Integrative Health (NCCIH)